期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 19, 期 16, 页码 4851-4856出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2009.06.022
关键词
Carbonic anhydrase; CA IX; CA XII; Acetazolamide; Tumor targeting
资金
- Swiss National Science Foundation [3100A0-105919/1]
- Swiss Cancer League (Robert-Wenner-Award)
- SWISSBRIDGE-Stammbach Foundation
- European Union [LSHC-CT-2006-037489]
- DIANA [LSHB-CT-2006037681]
- ADAMANT [HEALT-F2-2008-201342]
We describe the synthesis and characterization of two acetazolamide derivatives containing either a charged fluorophore or an albumin-binding moiety, which restrict binding to carbonic anhydrase IX and XII present on tumor cells. In vivo studies showed the preferentially targeting of tumor cells by the fluorescent acetazolamide derivative and the ability of the albumin-binding acetazolamide derivative to cause tumor retardation in a SK-RC-52 xenograft model of cancer. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据